You have until October 24, 2020 to:
- Re-watch sessions to make sure you got all the details
- Finish watching the presentations you didn’t reach
- Continue reviewing the e-posters
- Reach out to presenters and authors
- Keep the conversations going
You have until October 24, 2020 to:
Kelly Kohler, S.Laura Muzingwani and Toni Martins
Frederique Vink, Elisabeth Vodicka and Laura Mamo
Sona Chowdhury, Lisanne Verhoef and Luis Vela
IPVC 2020 – The 33rd International Papillomavirus Conference & Basic Science, Clinical and Public Health Workshops – will gather researchers, clinicians and other health professionals to share knowledge and ideas on papillomaviruses and their associated diseases, from basic science to global health impact.
By harnessing the power of innovation from HPV research, we can deliver on global prevention and control of HPV-related disease.
All virtual conference materials will be available for 3 months. The release date for all the sessions will be July 20, 2020.
Live sessions will take place between July 20-24, 2020.
All times stated in the program are in Central European Time (CET, GMT +1)
Professor Margaret Stanley
Department of Pathology
University of Cambridge
Director of Scale-up project Reproductive Health Global Program PATH
Professor, Departments of Molecular Genetics & Microbiology; Obstetrics and Gynecology, The University of New Mexico School of Medicine Co-Leader, Head and Neck Cancer Clinical Working Group, The University of New Mexico Comprehensive Cancer Center
Professor and Vice Chair for Translational Research Department of Pediatrics (Division of Genetic Medicine) Professor, Departments of Microbiology & Immunology; Epidemiology & Population Health; and, Obstetrics, Gynecology & Women's Health
Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, Department of Microbiology, RCH Honorary Research Fellow, Murdoch Childrens Research Institute Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia
Professor of Medicine at the University of California, San Francisco School of Medicine.
Director, Cancer Research Division Adjunct Professor, University of Sydney, School of Public Health | Conjoint Professor, UNSW Australia, Prince of Wales Clinical School
Postdoctoral Fellow, McGill University, Division of Cancer Epidemiology, Canada
Full Professor, Division of Experimental Virology Institute for Medical Virology and Epidemiology of Viral Diseases University of Tuebingen, Germany
Medical Director, Clinique A rue McGill, Medical Advisor at the STI Unit of Quebec’s National Public Health Institute
Professor and Director Center for Infection Research in Cancer (CIRC) H. Lee Moffitt Cancer Center & Research Institute
Jose Jeronimo, MD, is a gynecologic oncologist and currently serves as Chief Technical Officer for the Global Coalition against Cervical Cancer (GC3). He is also advisor for the Union for International Cancer Control (UICC), Geneva, in the evaluation, planning and implementation of cancer control plans in cities with more than one million inhabitants, including Cali (Colombia), Asuncion (Paraguay), Kumasi (Ghana) and Yangon (Myanmar)
Taylor Saunders-Wood is a Ph.D. student in the Division of Virology within the Department of Pathology at the University of Cambridge
Biochemistry & Molecular Genetics
University of Alabama
Senior consultant to the Cancer Epidemiology Research Program (CERP) at the Catalan Institute of Oncology (ICO) in Barcelona, Spain.
Chief of International Affairs at ICO and is the Executive Director of the ICO/IARC Information Centre on HPV and Cervical Cancer (www.who.int/hpvcentre).
Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine.
Associate Executive Chair for Clinical Research,
and Chair, Clinical Trials Committee for Pediatrics